Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Other Non-Current Liabilities

2.8 / 5 stars · 68/120 Roast Me

MYRIAD GENETICS, INC. Other Non-Current Liabilities

MYRIAD GENETICS, INC. (MYGN) had Other Non-Current Liabilities of $1.10 million as of 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-31

  • 2026-06-30: Other Liabilities, Noncurrent $1.10M.
  • 2026-03-31: Other Liabilities, Noncurrent $1.70M.
  • 2025-12-31: Other Liabilities, Noncurrent $1.90M; Other Liabilities, Noncurrent as first filed $1.70M.
  • 2025-09-30: Other Liabilities, Noncurrent $1.70M.
Period endOther Liabilities, NoncurrentOther Liabilities, Noncurrent as first filed
2026-06-30$1.10M
10-Q · filed 2026-07-31
2026-03-31$1.70M
10-Q · filed 2026-05-06
2025-12-31$1.90M
10-Q · filed 2026-07-31
$1.70M
10-K · filed 2026-02-24
2025-09-30$1.70M
10-Q · filed 2025-11-04
2025-06-30$1.90M
10-Q · filed 2025-08-06
2025-03-31$2.00M
10-Q · filed 2025-05-07
2024-12-31$2.20M
10-K · filed 2026-02-24
2024-09-30$34.30M
10-Q · filed 2024-11-08
2024-06-30$34.60M
10-Q · filed 2024-08-07
2024-03-31$40.60M
10-Q · filed 2024-05-08
2023-12-31$41.30M
10-K · filed 2025-02-28
2023-09-30$40.50M
10-Q · filed 2023-11-07
2023-06-30$11.40M
10-Q · filed 2023-08-04
2023-03-31$11.50M
10-Q · filed 2023-05-04
2022-12-31$18.00M
10-K · filed 2024-02-28
$14.50M
10-K · filed 2023-03-01
2022-09-30$4.60M
10-Q · filed 2022-11-02
2022-06-30$4.70M
10-Q · filed 2022-08-05
2022-03-31$4.90M
10-Q · filed 2022-05-06
2021-12-31$5.60M
10-K · filed 2023-03-01
2021-09-30$10.80M
10-Q · filed 2021-11-04
2021-06-30$13.80M
10-Q · filed 2021-08-04
2021-03-31$19.30M
10-Q · filed 2021-05-05
2020-12-31$14.70M
10-K · filed 2022-02-25
2020-09-30$10.70M
10-Q · filed 2020-11-09
2020-06-30$8.00M
10-KT · filed 2021-03-16
$4.30M
10-K · filed 2020-08-13
2019-09-30$7.30M
10-Q · filed 2019-11-06
2019-06-30$18.20M
10-KT · filed 2021-03-16
$7.80M
10-K · filed 2019-08-13
2019-03-31$7.30M
10-Q · filed 2019-05-08
2018-12-31$6.60M
10-Q · filed 2019-02-06
2018-09-30$6.30M
10-Q · filed 2018-11-07
2018-06-30$6.30M
10-K · filed 2019-08-13
2018-03-31$6.80M
10-Q · filed 2018-05-09
2017-12-31$6.60M
10-Q · filed 2018-02-07
2017-09-30$7.40M
10-Q · filed 2017-11-08
2017-06-30$7.20M
10-K · filed 2018-08-24
2017-03-31$21.50M
10-Q · filed 2017-05-03
2016-12-31$145.90M
10-Q · filed 2017-02-08
2016-09-30$1.10M
10-Q · filed 2016-11-02
2016-06-30$7.80M
10-K · filed 2017-08-09
$12.30M
10-K · filed 2016-08-10
2016-03-31$2.00M
10-Q · filed 2016-05-04
2015-12-31$2.00M
10-Q · filed 2016-02-03
2015-09-30$2.20M
10-Q · filed 2015-11-04
2015-06-30$3.90M
10-K · filed 2016-08-10
$8.80M
10-K · filed 2015-08-12
2015-03-31$6.42M
10-Q · filed 2015-05-06
2014-06-30$0.00
10-K · filed 2015-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92